How to Buy Tg Therapeutics Stock
Tg Therapeutics Inc
TG Therapeutics, Inc. , a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Tg Therapeutics stock last closed at $37.99, up 2.76% from the previous day, and has increased 169.43% in one year. It has overperformed other stocks in the Biotechnology industry by 2.46 percentage points. Tg Therapeutics stock is currently +193.81% from its 52-week low of $12.93, and -12.3% from its 52-week high of $43.32.
At the moment, there are 157.07M shares of TGTX outstanding. The market value of TGTX is $5.97B. In the past 24 hours, 1.28M TGTX shares were traded.
How to Buy Tg Therapeutics Stock
Not sure how to invest in Tg Therapeutics stock? Here's how.
- Decide where to buy Tg Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Tg Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your method of payment and add your information.
- Research Tg Therapeutics stock: The Tg Therapeutics ticker symbol is TGTX. Is Tg Therapeutics stock a good investment? Should you buy shares of TGTX? How do TGTX's underlying business fundamentals look? Do top analysts think Tg Therapeutics is a good buy? Why has TGTX's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if TGTX is a good stock to buy).
- Execute your TGTX trade: Decide if you will purchase TGTX shares at the current market price or use a limit order to buy TGTX stock at a given price.
- Get key alerts regarding your investment in TGTX: Create a watchlist to watch your position in Tg Therapeutics shares.
Step 1: Decide where to buy Tg Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy TGTX stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal details so you are able to buy TGTX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have opened your account on the best stock app for beginners, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing funds into your brokerage account.
Step 4: Research Tg Therapeutics stock
After you have decided on the best place to buy Tg Therapeutics stock, it's absolutely critical to research their stock before you buy, so you truly comprehend the risk and upside.
Tg Therapeutics shares at a glance
Tg Therapeutics Due Diligence Checks
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on TGTX's stock page.
What is the fair value of TGTX stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge TGTX's true value.
Using relative valuations metrics:
- TGTX may be undervalued based on its P/E ratio of 237.44x, relative to Biotechnology industry P/E ratio of -208.37x
- TGTX could be overvalued based on its P/B ratio of 26.83x, relative to Biotechnology industry P/B ratio of 4.16x
- TGTX could be overvalued based on its PEG ratio of 1.57x
You can do additional valuation research on TGTX's stock here.
Is TGTX a healthy company?
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the TGTX balance sheet.
- Total TGTX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the TGTX balance sheet.
- TGTX has $312.30M in cash and short term investments. This is enough to cover its annual cash burn of $40.56M.
- TGTX has cash burn of 40562000. It has sufficient cash and short-term investments to cover this for at least one year.
- TGTX profit margin has gone up from 5.4% to 7.1% in the past year.
Negative Health Checks:
- TGTX has a relatively high debt to equity ratio of 1.6.
Is TGTX stock a Buy, Hold, or Sell, according to analysts?
Out of 4 Equities analysts who track TGTX, the consensus analyst rating on Tg Therapeutics is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Tg Therapeutics stock forecast page.
TGTX Momentum
TGTX Performance Numbers
Last year, TGTX earnings were $23.38M. Over the past 1 years, TGTX's earnings have increased by 77.78% per year. This was faster than the Biotechnology industry average of 10.63%.
Last year, TGTX revenue was $329.00M. Over the past five year, TGTX's revenue has gone up by 364.59% per year. This was faster than the Biotechnology industry average of 44.4%.
You can analyze TGTX's earnings and revenue performance here.
Who is buying/selling TGTX?
In the last year, insiders at TGTX have sold more shares than they have bought.
Sean A. Power, CFO of TGTX, was the latest TGTX insider to sell. They sold $285,939.21 worth of TGTX stock on Jan 6, 2025.
Dig into more about who owns TGTX shares here.
Does TGTX stock generate passive income?
No, Tg Therapeutics doesn't provide an income stream by paying out dividends.
TGTX Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your TGTX trade
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price limit, place a limit order.
Press the Open button and eToro will place your order.
If you need more assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your investment in TGTX
Now that you own some shares in TGTX, you'll want to keep up with your shares.
Make a watchlist to get alerted to the latest events about your TGTX stock.
TGTX Feed
How to Buy Stock in Tg Therapeutics
To reiterate, here are the 6 steps for buying Tg Therapeutics stock:
- Decide where to buy Tg Therapeutics stock
- Open your brokerage account
- Deposit money your brokerage account
- Research Tg Therapeutics stock
- Execute your TGTX trade
- Get key alerts regarding your investment in TGTX
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Tg Therapeutics, create a watchlist today.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.